Document is current
Any future updates will be listed below
-
Authors
Xiao, Yinzong
Wallace, Jack
Ahad, Marvad
van Gemert, Caroline
Thompson, Alexander J.
Doyle, Joseph
Lam, Ho Yin
Chan, Kico
Bennett, Gabrielle
Adamson, Emily
Yussf, Nafisa
Tang, Aurora
Pedrana, Alisa
Stoove, Mark
Hellard, Margaret
Howell, Jessica
- License Information
-
More Information
Article History
Received: 28 March 2021
Accepted: 1 October 2021
First Online: 15 October 2021
Declarations
:
: Ethics approval was obtained from the Alfred Hospital Ethics Committee (147/19) and Cancer Council Ethics Committee (HREC 1903). All participants provided written informed consent to participate in this study.
: Not applicable.
: MH receives funding from Gilead Sciences and Abbvie for investigator-initiated research. JH has received speaker fees and investigator-initiated grants from Gilead Sciences. AJT has received consulting fees from Gilead, Abbvie, Roche, BMS, Merck, Immunocore, Janssen, Assembly Biosciences, Arbutus, Eisai, Ipsen and Bayer, speaker fees from Gilead Sciences, and investigator-initiated grants from Gilead Sciences. JD’s institution has received investigator-initiated research funding from Gilead Sciences, Merck, AbbVie and Bristol Myers Squibb, and consulting fees from Gilead, AbbVie and Merck. MS receives funding from Gilead Sciences and Abbvie for investigator-initiated research and consultant fees from Gilead Sciences for activities unrelated to this work.
